The association of hyperestrogenemia with coronary thrombosis in men

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 16, Issue 11, 1996, Pages 1383-1387

  Phillips, Gerald B ^a,b   Pinkernell, Bruce H ^a   Jing, Tian Yi ^a  

^a St Luke's Roosevelt Hospital Center ^*  (United States)

^b ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

Author keywords

coronary thrombosis; estradiol; estrogen; myocardial infarction; testosterone

Indexed keywords

CARDIOVASCULAR AGENT; ESTRADIOL; ESTROGEN; ORAL ANTIDIABETIC AGENT; TESTOSTERONE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY THROMBOSIS; ESTROGEN BLOOD LEVEL; HEART INFARCTION; HUMAN; MALE; PRIORITY JOURNAL; RISK FACTOR;

EID: 0029861445     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.16.11.1383     Document Type: Article

References (43)

1. Phillips GB, Pinkernell BH, Jing TY. The association of hypotestosteronemia with coronary artery disease in men. Arterioscler Thromb. 1994:14:701-706.
2. The Coronary Drug Project. JAMA. 1970;214:1303-1313.
3. Judkins MP. Selective coronary arteriography, I: a percutaneous transfemoral technic. Radiology. 1967:89:815-824.
4. Blumgart HL, Schlesinger MJ, Davis D. Studies on the relation of the clinical manifestations of angina pectoris, coronary thrombosis, and myocardial infarction to the pathologic findings. Am Heart J. 1940:19:1-91.
5. DeWood MA, Spores J, Notske R, Mouser LT, Burroughs R, Golden MS, Lang HT. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N Engl J Med. 1980; 303:897-902.
6. Rivin AU, Dimitroff SP. The incidence and severity of atherosclerosis in estrogen-treated males, and in females with a hypoestrogenic or a hyperestrogenic state. Circulation. 1954:9:533-539.
7. London WT, Rosenberg SE, Draper JW, Almy TP. The effect of estrogens on atherosclerosis. Ann Intern Med. 1961:55:63-69.
8. Fortin CJ, Klein T, Messmore HL, O'Connell JB. Myocardial infarction and severe thromboembolic complications as seen in an estrogen-dependent transsexual. Arch Intern Med. 1984; 144: 1082-1083.
9. Small M, Lowe GDO, Beastall GH, Beattie JM, McEachern M, Hutton I, Lorimer AR, Forbes CD. Serum oestradiol and ischaemic heart disease: relationship with myocardial infarction but not coronary atheroma or haemostasis. Q J Med. 1985:223:775-782.
10. Yang XC, Jing TY, Resnick LM, Phillips GB. Relation of hemostatic risk factors to other risk factors for coronary heart disease and to sex hormones in men. Arterioscler Thromb. 1993:13:467-471.
11. Ogston D. The Physiology of Hemostasis. Cambridge, Mass: Harvard University Press; 1983.
12. Wessler S. Estrogen-associated thromboembolism. Ann Epidemiol. 1992;2:439-443.
13. Lobo RA. Estrogen and the risk of coagulopathy. Am J Med. 1992;92:283-285.
14. Jaffe MD. Effect of oestrogens on postexercise electrocardiogram. Brit Heart J. 1977;38:1299-1303.
15. Klaiber EL, Broverman DM, Haffajee CI, Hochman JS, Sacks GM, Dalen JE. Serum estrogen levels in men with acute myocardial infarction. Am J Med. 1982:73:872-880.
16. Maseri A, L'Abbate A, Baroldi G, Chierchia S, Marzilli M, Ballestra AM, Severi S, Parodi O, Biagini A, Distante A, Pesola A. Coronary vasospasm as a possible cause of myocardial infarction. N Engl J Med. 1978:299:1271-1277.
17. Davies MJ, Thomas A. Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic death. N Engl J Med. 1984;310: 1137-1140.
18. Pirke KM, Doerr P. Age related changes and interrelationships between plasma testosterone, oestradiol, and testosterone-binding globulin in normal adult males. Acta Endocrinol. 1973; 74:792-800.
19. Schneider G, Kirschner MA, Berkowitz R, Ertel NH. Increased estrogen production in obese men. J Clin Endocrinol Metab. 1979:48:633-638.
20. Stoffer SS, Hynes KM, Jiana N, Ryan RJ. Digoxin and abnormal serum hormone levels. JAMA. 1973;225:1643-1644.
21. Tappler B, Katz M. Pituitary-gonadal dysfunction in low-output cardiac failure. Clin Endocrinol. 1979:10:219-226.
22. Phillips GB. The variability of the serum estradiol level in men: effect of stress (college examinations), cigarette smoking, and coffee drinking on the serum sex hormone and other hormone levels. Steroids. 1992:57:135-141.
23. Longcope C, Kato T, Horton R. Conversion of blood androgens to estrogens in normal adult men and women. J Clin Invent. 1969; 48:2191-2201.
24. Phillips GB. Relationship of serum sex hormones to coronary heart disease. Steroids. 1993;58:286-290,554-555.
25. Phillips GB, Yano K, Stemmermann GN. Serum sex hormone levels and myocardial infarction in the Honolulu Heart Program: pitfalls in prospective studies on sex hormones. J Clin Epidemiol. 1988; 41:1151-1156.
26. Phillips GB. Relationship between serum sex hormones and the glucose-insulin-lipid defect in men with obesity. Metabolism. 1993; 42:116-120.
27. Phillips GB. Evidence for hyperoestrogenaemia as a risk factor for myocardial infarction in men. Lancet. 1976;2:14-18.
28. Phillips GB, Castelli WP, Abbott RD, McNamara PM. Association of hyperestrogenemia and coronary heart disease in men in the Fraingham cohort. Am J Med. 1983;74:863-869.
29. Rosenthal MB, Barnard J, Rose DP, Inkeles S, Hall J, Pritikin N. Effects of a high-complex-carbohydrate, low-fat, low-cholesterol diet on levels of serum lipids and estradiol. Am J Med. 1985;78:23-27.
30. Stanik S, Dornfeld LP, Maxwell MH, Viosca SP, Korenman SG. The effect of weight loss on reproductive hormones in obese men. J Clin Endocrinol Metab. 1981;53:828-832.
31. Lindholm J, Winkel P, Brodthagen U, Gyntelberg F. Coronary risk factors and plasma sex hormones. Am J Med. 1982;73:648-651.
32. Mendoza SG, Carasco H, Zerpa A, Briceno Y, Rodriguez F, Speirs J, Glueck CJ. Effect of physical training on lipids, lipoproteins, apolipoproteins, lipases, and endogenous sex hormones in men with premature myocardial infarction. Metabolism. 1991;40:368-377.
33. Stampfer MJ, Colditz GA. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med. 1991;20:47-63.
34. Phillips GB. Relationship between serum sex hormones and glucose, insulin, and lipid abnormalities in men with myocardial infarction. Proc Natl Acad Sci USA. 1977;74:1729-1733.
35. Phillips GB. Sex hormones, risk factors and cardiovascular disease. Am J Med. 1978;65:7-11.
36. ffrench-Constant CK, Spengel FA, Thompson GR. Hyperlipidaemia and premature coronary artery disease associated with sex-change in a female. Postgrad Med J. 1985;61:6l-63.
37. Wild RA, Grubb B, Hartz A, Van Nort JJ, Bachman W, Bartholomew M. Clinical signs of androgen excess as risk factors for coronary artery disease. Fertil Steril. 1990;54:255-259.
38. Marin P, Holmang S, Jonsson L, Sjostrom L, Kvist H, Holm G, Lindstedt G, Bjorntorp P. The effects of testosterone treatment on body composition and metabolism in middle-aged obese men. Int J Obes. 1992:16:991-997.
39. Tenover JS. Effects of testosterone supplementation in the aging male. J Clin Endocrinol Metab. 1992;75:1092-1098.
40. Barrett-Connor E, Wingard DL, Criqui MH. Postmenopausal estrogen use and heart disease risk factors in the 1980s. JAMA. 1989; 261:2095-2100.
41. Lindsay R. Estrogens, bone mass, and osteoporotic fracture. Am J Med. 1991;91:10S-13S.
42. Horowitz M, Wishart JM, O'Loughlin PD, Morris HA, Need AG, Nordin BEC. Osteoporosis and Klinefelter's syndrome. Clin Endocrinol. 1992:26:113-118.
43. Ditkoff EC, Crary WG, Cristo M, Lobo RA. Estrogen improves psychological function in asymptomatic postmenopausal women. Obstet Gynecol. 1991;78:991-995.